Double trouble: Cyclosporine‑induced thrombocytosis in a patient with methotrexate toxicity: Are they related?
Cherukuri Tejaswi1★, Saritha Mohanan1, Rangaraj Murugaiyan1, Kaliaperumal Karthikeyan1★ Corresponding author
- 1Department of Dermatology, Sri Manakula Vinayagar Medical College and Hospital, Kalitheerthalkuppam, Puducherry, India.
CORRESPONDENCE
Cherukuri Tejaswi
Department of Dermatology, Sri Manakula Vinayagar Medical College and Hospital, Kalitheerthalkuppam, Puducherry, India.
Received: 09-05-2014; Revised: 21-06-2014; Accepted: 22-01-2015.
Volume 6, Issue 3 · pp. 160–162 · PUBLISHED 2015 · DOI: 10.4103/0976-500X.162005
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Psoriasis is a common, chronic, disfiguring, inflammatory, and proliferative condition of the skin. It manifests with varying degrees of severity and can be treated with various immune modulators. This is a case report of a 57‑year‑old male patient of psoriasis on long‑term oral methotrexate, who developed methotrexate toxicity when given an injection of methotrexate for unstable psoriasis. After recovery, the patient was started on cyclosporine 100 mg twice a day. After a week, he developed thrombocytosis, which reverted a week after cyclosporine was stopped. The patient is currently being managed with acitretin. The aim of this case report is to emphasize the various unpredictable adverse reactions encountered during treatment of psoriasis, especially when a combination or sequential treatment is used. There is a need for caution, as late sequelae of long‑term administration of the systemic agents used in the treatment of psoriasis are still unknown.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Tejaswi, C., Mohanan, S., Murugaiyan, R., & Karthikeyan, K. (2015). Double trouble: Cyclosporine‑induced thrombocytosis in a patient with methotrexate toxicity: Are they related?. Journal of Pharmacology and Pharmacotherapeutics, 6(3), 160–162. https://doi.org/10.4103/0976-500X.162005
